Cargando…

Involvement of the heart in Kawasaki Disease: not always coronaritis

Detalles Bibliográficos
Autores principales:	Pellegrin, MC, Taddio, A, Giurici, N, Lepore, L, Ventura, A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194574/ http://dx.doi.org/10.1186/1546-0096-9-S1-P214

Ejemplares similares

PReS-FINAL-2043: Cardiac involvement in juvenile idiopathic arthritis
por: Rossetto, E, et al.
Publicado: (2013)

The outbreak of Rheumatic Fever in the city of Trieste
por: De Cunto, A, et al.
Publicado: (2008)

1189. COVID 19 Infection in Children in Colombia, Experience from a Nationwide Network (CORONARED)
por: Mesa-Monsalve, Juan Gonzalo, et al.
Publicado: (2021)

PReS-FINAL-2088: Risk of severe adverse events in juvenile idiopathic arthritis and pediatric-onset inflammatory bowel disease, treated with anti-tnf drugs
por: Vatta, P, et al.
Publicado: (2013)

PReS-FINAL-2240: Serum amyloid protein a concentration in CAPS patients treated with anti IL1Β
por: Pastore, S, et al.
Publicado: (2013)

Recurrent refractory Kawasaki disease
por: Costa Reis, P, et al.
Publicado: (2011)

Can neutrophil-to-lymphocyte ratio predict cardiac involvement in kawasaki disease?
por: Gücenmez, Özge Altuğ, et al.
Publicado: (2014)

Cysts: are they always benign?
por: Chandrasekharan, S, et al.
Publicado: (2004)

Is faster always better?
por: Hamila, MA, et al.
Publicado: (2006)

Kawasaki disease in Sicily: a 7 year survey
por: Vitale, A, et al.
Publicado: (2008)

Circulating levels of the adipocytokines vaspin and omentin in patients with Kawasaki disease
por: Cantarini, L, et al.
Publicado: (2011)

Kawasaki disease in a northern region of Italy
por: Corinaldesi, Elena, et al.
Publicado: (2011)

CMR feature tracking in Kawasaki Disease convalescence
por: Bratis, Konstantinos, et al.
Publicado: (2015)

5-aminoimidazole-4-carboxamide ribonucleotide-transformylase and inosine-triphosphate-pyrophosphatase genes variants predict remission rate during methotrexate therapy in patients with juvenile idiopathic arthritis
por: Pastore, Serena, et al.
Publicado: (2014)

Chronic recurrent multifocal osteomyelitis: experience from a single pediatric rheumatology center over the past ten years
por: Pastore, Serena, et al.
Publicado: (2014)

Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic
por: Simonini, G, et al.
Publicado: (2011)

Coronary vessel wall assessment after Kawasaki Disease
por: Hussain, Tarique, et al.
Publicado: (2011)

Forever interesting disease: Kawasaki vasculitis – case series
por: Selmanovic, Velma, et al.
Publicado: (2014)

Incidence and clinical features of kawasaki disease in Catalonia (Spain)
por: Sanchez-Manubens, Judith, et al.
Publicado: (2014)

Predictors of delayed treatment of Kawasaki disease in community and tertiary care hospitals
por: Luca, Nadia, et al.
Publicado: (2012)

NSAID intolerance: it is not always what it seems
por: Petkovic, Tatjana Pecaric, et al.
Publicado: (2014)

Atypical onset as predictor of poor outcome in Pediatric Systemic Lupus Erythematosus (pSLE)
por: Taddio, A, et al.
Publicado: (2008)

Coronary artery abnormalities in Kawasaki disease according to patient age
por: Nuñez, Esmeralda, et al.
Publicado: (2011)

Preoperative assessment of patients undergoing abdominal aortic surgery: chronic kidney disease is almost always present
por: Turley, A, et al.
Publicado: (2007)

Kawasaki shock syndrome: a case report
por: Marrani, Edoardo, et al.
Publicado: (2014)

Peripheric arterial aneurisyms and monocytosis in intravenous immunoglobulin treatment resistant Kawasaki disease
por: Baskin, E, et al.
Publicado: (2008)

Risk factors for refractory Kawasaki disease: clinical records of the paediatric clinic of palermo
por: Maggio, Maria Cristina, et al.
Publicado: (2014)

Kawasaki disease in France, Kawanet: incomplete forms are frequent and associated with a high frequency of cardiac complications
por: Koné-Paut, I, et al.
Publicado: (2014)

The role of Inositol 1,4,5 triphosphate kinase C in the pathogenesis of Kawasaki disease
por: Khajoee, Vahid, et al.
Publicado: (2011)

Macrophage migration inhibitory factor gene polymorphisms in an Italian cohort of patients with Kawasaki disease
por: Simonini, G, et al.
Publicado: (2008)

SHARE – workpackage 5: evidence-based recommendations for diagnosis and treatment of kawasaki disease and henoch schönlein purpura
por: de Graeff, Nienke, et al.
Publicado: (2014)

Rising incidence of Kawasaki disease in Chile: analysis of national discharge databases between 2001 and 2007
por: Borzutzky, Arturo, et al.
Publicado: (2012)

PReS-FINAL-2317: Clinical presentation, management and outcome of Kawasaki disease (4 years reviews)
por: Benamer, HM, et al.
Publicado: (2013)

Prospective analysis of Kawasaki disease cases in Catalonia (Spain) from March 2013 to March 2014
por: Sanchez-Manubens, Judith, et al.
Publicado: (2014)

High incidence of adrenal suppression in children with Kawasaki disease treated with intravenous immunoglobulin plus prednisolone
por: Goto, Masahiro, et al.
Publicado: (2015)

Subclinical aterosclerosis and Kawasaki Disease (KD): results from an e- tracking study of arterial stiffness in a Sicilian population
por: Vitale, A, et al.
Publicado: (2008)

Clinical significance of hyper-IGA in a pediatric laboratory series
por: Pastore, Serena Ifmach, et al.
Publicado: (2014)

Delay in diagnosing Kawasaki disease. Identifying the root cause at the referral base of a regional children’s hospital
por: Vidal, Daniela, et al.
Publicado: (2012)

FOXP3 Polymorphism and gene expression in Italian patients with Kawasaki Syndrome
por: Simonini, G, et al.
Publicado: (2008)

Abnormal myocardial perfusion pattern in convalescent Kawasaki Disease patients assessed by stress perfusion cardiovascular magnetic resonance
por: Bratis, Konstantinos, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ikc89ksnvdo3a9au7t5o615iav